Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Lucintel | PRODUCT CODE: 1387372

Cover Image

PUBLISHER: Lucintel | PRODUCT CODE: 1387372

Pollen Allergy Market Report: Trends, Forecast and Competitive Analysis to 2030

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4850
PDF (2 Users License)
USD 5800
PDF (5 Users License)
USD 6700
PDF (Corporate License)
USD 8850

Add to Cart

Pollen Allergy Trends and Forecast

The future of the global pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets. The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030 with a CAGR of 4.5% from 2024 to 2030. The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

A more than 150-page report is developed to help in your business decisions.

Pollen Allergy by Segment

The study includes a forecast for the global pollen allergy by therapeutics drug class, product type, allergen type, end use, and region.

Pollen Allergy Market by Therapeutics Drug Class [Shipment Analysis by Value from 2018 to 2030]:

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Auto Injectable Epinephrine
  • Immunotherapy

Pollen Allergy Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Services

Pollen Allergy Market by Allergen Type [Shipment Analysis by Value from 2018 to 2030]:

  • Food
  • Inhaled
  • Drug
  • Others

Pollen Allergy Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Diagnostic Laboratories
  • Hospitals
  • Others

Pollen Allergy Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Pollen Allergy Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies pollen allergy companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the pollen allergy companies profiled in this report include-

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Pollen Allergy Market Insights

Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Within this market, inhaled will remain the largest segment due to high growth of respiratory allergies.

APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Features of the Global Pollen Allergy Market

Market Size Estimates: Pollen allergy market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Pollen allergy market size by various segments, such as by therapeutics drug class, product type, allergen type, end use, and region in terms of value ($B).

Regional Analysis: Pollen allergy market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different therapeutics drug classes, product types, allergen types, end uses, and regions for the pollen allergy market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the pollen allergy market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the pollen allergy market size?

Answer: The global pollen allergy market is expected to reach an estimated $7.2 billion by 2030.

Q2. What is the growth forecast for pollen allergy market?

Answer: The global pollen allergy market is expected to grow with a CAGR of 4.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the pollen allergy market?

Answer: The major drivers for this market are growing occurence of allergies, rising awareness towards allergies and their management, and on-going technological advancements.

Q4. What are the major segments for pollen allergy market?

Answer: The future of the pollen allergy market looks promising with opportunities in the food, inhaled, and drug markets.

Q5. Who are the key pollen allergy market companies?

Answer: Some of the key pollen allergy companies are as follows:

  • ALK-Abello
  • Circassia
  • DBV Technologies
  • Genentech
  • GlaxoSmithKline
  • HAL Allergy
  • Johnson & Johnson
  • Meda AB
  • Merck & Co
  • Mylan

Q6. Which pollen allergy market segment will be the largest in future?

Answer: Lucintel forecasts that corticosteroids will remain the largest region over the forecast period due to its effectiveness, safety, and availabiliy.

Q7. In pollen allergy market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to high prevalence of pollen allergies and presence of unmet healthcare infrastructure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the pollen allergy market by therapeutics drug class (antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy), product type (instruments, consumables, and services), allergen type (food, inhaled, drug, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Pollen Allergy Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Pollen Allergy Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Pollen Allergy Market by Therapeutics Drug Class
    • 3.3.1: Antihistamines
    • 3.3.2: Decongestants
    • 3.3.3: Corticosteroids
    • 3.3.4: Mast Cell Stabilizers
    • 3.3.5: Leukotriene Inhibitors
    • 3.3.6: Nasal Anticholinergics
    • 3.3.7: Immunomodulators
    • 3.3.8: Auto injectable Epinephrine
    • 3.3.9: Immunotherapy
  • 3.4: Global Pollen Allergy Market by Product Type
    • 3.4.1: Instruments
    • 3.4.2: Consumables
    • 3.4.3: Services
  • 3.5: Global Pollen Allergy Market by Allergen Type
    • 3.5.1: Food
    • 3.5.2: Inhaled
    • 3.5.3: Drug
    • 3.5.4: Others
  • 3.6: Global Pollen Allergy Market by End Use
    • 3.6.1: Diagnostic Laboratories
    • 3.6.2: Hospitals
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Pollen Allergy Market by Region
  • 4.2: North American Pollen Allergy Market
    • 4.2.2: North American Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.3: European Pollen Allergy Market
    • 4.3.1: European Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.3.2: European Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.4: APAC Pollen Allergy Market
    • 4.4.1: APAC Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.4.2: APAC Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others
  • 4.5: ROW Pollen Allergy Market
    • 4.5.1: ROW Pollen Allergy Market by Therapeutics Drug Class: Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy
    • 4.5.2: ROW Pollen Allergy Market by Allergen Type: Food, Inhaled, Drug, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Pollen Allergy Market by Therapeutics Drug Class
    • 6.1.2: Growth Opportunities for the Global Pollen Allergy Market by Product Type
    • 6.1.3: Growth Opportunities for the Global Pollen Allergy Market by Allergen Type
    • 6.1.4: Growth Opportunities for the Global Pollen Allergy Market by End Use
    • 6.1.5: Growth Opportunities for the Global Pollen Allergy Market by Region
  • 6.2: Emerging Trends in the Global Pollen Allergy Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Pollen Allergy Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Pollen Allergy Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: ALK-Abello
  • 7.2: Circassia
  • 7.3: DBV Technologies
  • 7.4: Genentech
  • 7.5: GlaxoSmithKline
  • 7.6: HAL Allergy
  • 7.7: Johnson & Johnson
  • 7.8: Meda AB
  • 7.9: Merck & Co
  • 7.10: Mylan
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!